Want to know if this job is worth applying to?
Redwood City, California, United States
Remote only
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity
We are hiring an Executive Director of Global Commercial Development, reporting to VP Pancreatic Cancers. The role will work within a growing and fluid Global Commercial Development organization. Roles will continuously evolve as the team grows and portfolio priorities shift across multiple indications and assets. The role will have 2-3 direct reports. This position can be based out of Redwood City (CA), Plainsboro (NJ) or remote.
Responsibilities often include:
Disease Area Strategy (DAS): Partner with clinical, commercial, medical, access and others to ensure DAS evolves and priorities shift based on latest evidence (internal, competitive). Support prioritization of future assets for development, in-licensing, or combinations. Partner with BD. Be an integrator and conduit of sharing commercial and clinical insights across functions.
Multi-year Global Commercialization Plan: Partner and lead with Medical and Market Access to build goals, track goals, and refresh the multi-year commercialization plan for pancreatic cancer that cuts across assets and indications. Share learnings with Lung and CRC teams and coordinate to provide input into cross-tumor plan as well.
Enable Brand Pan-Tumor Strategic Elements: Partner with Pancreatic cancer and other tumor commercial and medical teams to align and deliver strategic elements that should be consistent across indications (e.g., overarching positioning, global brand campaign, brand book, consistent dosing/MOA messages). Increase communication and collaboration across multiple teams. Strengthen communication and collaboration across teams and ensure shared strategic elements are implemented consistently.
KOL Coordination: Lead global thought leader strategy and coordination: Lead the Senior Director, Global Thought Leader Strategy & Engagement for pancreatic cancers. Guide the development of a strategic approach to global thought leader engagement across the portfolio, coordinate external engagement priorities and relationships, and ensure insights from these interactions inform disease area and commercial strategies. Lead Senior Director, Global Thought Leader Strategy & Engagement for pancreatic cancers, will serve as the strategic architect for global thought leader engagement across the portfolio and coordinate external relationships.
Operational Excellence: Operating in a build-while-scaling environment, this leader will help shape how complex, cross-functional work gets done - bringing clarity, structure, and momentum while partnering closely with senior leaders. Support team meetings for Pancreatic Cancer GCD teams to ensure well-prepared, broad input, and seamless. Plan team building initiatives to build a strong culture. Build team culture, communications, and efficiency. Drive coordinated annual planning processes (e.g., brand planning, forecast updates) for Pancreatic cancers.
Lead Pancreatic Cancer teammate providing into early development: Lead director or senior director who coordinates pancreatic commercial input to feed into the early development commercial team. Attend early asset meetings on agenda-driven basis.
Lead portfolio narrative and co-positioning strategy projects: Lead the creation and ongoing evolution of a compelling pancreatic cancer portfolio narrative that articulates the disease area opportunity, portfolio strategy, and role of each brand and indication. Drive alignment across brand and indication teams on co-positioning, portfolio-level messages, and the relationship among assets, while ensuring brand strategies remain clearly differentiated and grounded in their clinical profiles.
Travel as needed (typically up to 30-45%).
Required Experience, Skills, and Education:
Bachelor's degree required; advanced degree (MBA, PhD, PharmD, or equivalent) preferred.
15+ years of progressive commercial experience in biotechnology and/or pharmaceuticals, including global strategic marketing or global brand responsibilities; local/affiliate marketing experience required as well.
Deep oncology expertise: Strong understanding of oncology drug development and the cancer treatment landscape, including evolving standards of care, clinical practice, and unmet needs. Experience in pancreatic cancer is valuable; broader oncology experience with the ability to quickly build disease-area expertise is also relevant.
Ability to interpret clinical evidence: Demonstrated ability to understand clinical data, study design, and development strategy, and to assess their implications for patients, treatment pathways, and the commercial opportunity across assets and indications.
Effective partnership with Medical: Experience collaborating with Medical Affairs and Clinical Development as a trusted commercial partner—bringing a distinct commercial perspective, incorporating medical and scientific expertise, and working within clear functional roles and responsibilities.
Influence and alignment across teams: Strong ability to build relationships, facilitate constructive discussion, and influence cross-functional stakeholders without relying on direct authority. Can help teams reach a shared interpretation of evidence and translate aligned perspectives into portfolio and brand strategies.
Experience supporting commercialization organizations, including involvement in launch readiness, brand planning, operational planning, and capability buildout.
Demonstrated Executive Director-level capability, including defining operating models, building scalable organizational capabilities, and driving cross-functional alignment in evolving organizations.
Demonstrated track record developing and executing global brand strategies and translating insights into executable plans and deliverables.
Launch experience (global, regional, or major market) with responsibility for core brand strategy, messaging, and enabling assets.
Proven success partnering with senior commercial, medical, sales, analytics, and access leaders to enable organizational effectiveness.
Experience building and scaling high-performing teams and organizational capabilities.
Track record of thriving in ambiguous, fast-moving environments with a hands-on, builder mindset.
Exceptional communication and interpersonal skills, with the ability to translate complexity into clear and actionable frameworks.
Possess an entrepreneurial mindset, with tolerance for ambiguity, strong bias towards action, and a passion for impacting the lives of cancer patients.
Proven experience represent companies like Revolution Medicines externally with impressive results and relationships.
#LI-JW1 #LI-Remote
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.
